Fig 1.
SKDB: Shizuoka Kokuho Database.
Fig 2.
Flow diagram of study cohort enrollment.
NHI: National Health Insurance, LSMSCE: Late-Stage Medical Care System for the Elderly.
Table 1.
Baseline characteristics of BZRA group and suvorexant group before propensity score matching.
Fig 3.
Time-specific hazard estimates.
The BZRA and suvorexant groups had a higher risk of hip fracture events immediately after initiation of oral therapy, with the suvorexant group having a higher risk than the BZRA group. BZRA: benzodiazepine receptor agonist.
Table 2.
Baseline characteristics of BZRA group and suvorexant group after propensity score matching.
Fig 4.
HR: hazard ratio, CI: confidence interval, BZRA: benzodiazepine receptor agonist.